Literature DB >> 26080904

Diabetic ketoacidosis and electroencephalographic changes in newly diagnosed pediatric patients.

Mark T Mackay1, Charlotte Molesworth2, Elisabeth A Northam3,4, Terrie E Inder5, Fergus J Cameron4,6.   

Abstract

OBJECTIVE: To document electroencephalogram (EEG) changes and their correlation with clinical parameters in a newly diagnosed pediatric cohort of type 1 diabetes mellitus (T1DM) patients with and without diabetic ketoacidosis (DKA) and to define their medium term utility and significance. RESEARCH DESIGN AND METHODS: Prospective longitudinal study of children presenting with T1DM. EEGs were performed within 24 h of diagnosis, day 5, and at 6 months post-diagnosis and reviewed by a neurologist blinded to clinical status. Severity of encephalopathy was graded from 1 to 5 using the Aoki and Lombroso encephalopathy scale. Cognitive abilities were assessed using standardized tests of attention, memory, and intelligence.
RESULTS: Eighty eight children were recruited; 34 presented with DKA. Abnormal background slowing was more often observed in the first 24 h in children with DKA (p = 0.01). Encephalopathy scores on day 1 correlated with initial pH, CO2 , HCO3 , base excess, respiratory rate, heart rate, diastolic blood pressure, and IV fluid intake (all parameters p < 0.05). EEG scores at day 1 did not correlate with contemporaneous mental state or cognition in the medium term.
CONCLUSIONS: DKA was associated with significant clinical and neurophysiologic signs of brain dysfunction at presentation. While EEG is sensitive to the detection of encephalopathy in newly diagnosed T1DM, it has limited use in identifying children at risk of later cognitive deficits.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  DKA; EEG; brain

Mesh:

Year:  2015        PMID: 26080904     DOI: 10.1111/pedi.12284

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  3 in total

1.  Epilepsy and behavioral changes, type 1 diabetes mellitus and a high titer of glutamic acid decarboxylase antibodies.

Authors:  Esther Ganelin-Cohen; Dalit Modan-Moses; Rina Hemi; Hannah Kanety; Bruria Ben-Zeev; Christiane S Hampe
Journal:  Pediatr Diabetes       Date:  2015-12-29       Impact factor: 4.866

2.  Clinical presentation and memory function in youth with type 1 diabetes.

Authors:  Katherine Semenkovich; Allison Bischoff; Tasha Doty; Suzanne Nelson; Alejandro F Siller; Tamara Hershey; Ana Maria Arbeláez
Journal:  Pediatr Diabetes       Date:  2015-09-17       Impact factor: 4.866

3.  Cognitive Function Following Diabetic Ketoacidosis in Children With New-Onset or Previously Diagnosed Type 1 Diabetes.

Authors:  Simona Ghetti; Nathan Kuppermann; Arleta Rewers; Sage R Myers; Jeff E Schunk; Michael J Stoner; Aris Garro; Kimberly S Quayle; Kathleen M Brown; Jennifer L Trainor; Leah Tzimenatos; Andrew D DePiero; Julie K McManemy; Lise E Nigrovic; Maria Y Kwok; Clinton S Perry; Cody S Olsen; T Charles Casper; Nicole S Glaser
Journal:  Diabetes Care       Date:  2020-09-22       Impact factor: 19.112

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.